CORVUS PHARMACEUTICALS INC
CRVSNASDAQ🏆 #2477 by market capEarnings Nov 3US Equity
$11.76▼ $0.11 (−0.93%)
🌙 After hours$11.76▲ 0.00%Regular close · extended-hours price shownTrack CRVS
Get earnings, price moves & breaking news on Telegram
24h▼ 0.9%
7d▼ 12.6%
14d▼ 9.3%
30d▼ 16.9%
ytd▲ 53.0%
1y▲ 61.2%
🏦Market Cap
$989M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
64
Fair
CORVUS PHARMACEUTICALS INC
CRVSAnalyst Ratings
Price
$11.76
Total
13
Raised
1
Lowered
0
Avg PT
$40.00
H / L
$40 / $40
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Oppenheimer | Reiterated | Outperform | 2026-03-13 | $32.00 | +172.10% |
Jefferies | Reiterated | Buy | 2026-01-22 | $42.00 | +257.10% |
Barclays | Reiterated | Overweight | 2026-01-21 | $28.00 | +138.10% |
HC Wainwright & Co. | Reiterated | Buy | 2026-01-20 | — | — |
Mizuho | Reiterated | Outperform | 2025-05-20 | — | — |
Ladenburg Thalmann | Reiterated | Buy | 2024-09-16 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2023-09-07 | — | — |
Wedbush | Reiterated | Outperform | 2020-03-13 | — | — |
H.C. Wainwright | Reiterated | Buy | 2020-03-10 | $27.00 | +129.60% |
Roth Capital | Reiterated | Buy | 2019-05-29 | — | — |
Credit Suisse | Upgraded | Underperform → Neutral | 2017-08-24 | — | — |
BTIG Research | Reiterated | Buy | 2016-04-19 | — | — |
Guggenheim | Reiterated | Buy | 2016-04-18 | — | — |
Institution
Oppenheimer
Reiterated · Outperform · 2026-03-13
$32.00
+172.10%
Jefferies
Reiterated · Buy · 2026-01-22
$42.00
+257.10%
Barclays
Reiterated · Overweight · 2026-01-21
$28.00
+138.10%
HC Wainwright & Co.
Reiterated · Buy · 2026-01-20
—
—
Mizuho
Reiterated · Outperform · 2025-05-20
—
—
Ladenburg Thalmann
Reiterated · Buy · 2024-09-16
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2023-09-07
—
—
Wedbush
Reiterated · Outperform · 2020-03-13
—
—
H.C. Wainwright
Reiterated · Buy · 2020-03-10
$27.00
+129.60%
Roth Capital
Reiterated · Buy · 2019-05-29
—
—
Credit Suisse
Upgraded · Underperform → Neutral · 2017-08-24
—
—
BTIG Research
Reiterated · Buy · 2016-04-19
—
—
Guggenheim
Reiterated · Buy · 2016-04-18
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space